Institution profile

LIGHT CLINIC GINZA

Explore the institution's name, address and registered technologies as published, along with plan classifications, score components and sources.

The ranking reflects only the registration data published by Japan's Ministry of Health, Labour and Welfare; it does not represent treatment outcomes or quality of care. Scoring method →

Source: Ministry of Health, Labour and Welfare public directory of regenerative medicine providers MHLW e-Regenerative Medicine public register · Directory archive date I: 2026-07-19 / II: 2026-09-26 / III: 2026-05-18 · Internet Archive

MHLW e-Regenerative Medicine public registerPublic document number 01C2407045 +2

Location

Prefecture
Tokyo
Address
中央区銀座1-14-6 GINZA LOUIS 10階

Plan classification

  • Class INot registered
  • Class IINot registered
  • Class IIIThe low-risk category under the law.

Certified committee for regenerative medicine

  • 同仁会認定再生医療等委員会
  • 患者の集いモミの木再生医療等委員会

Public score

29.5/ 100

A · Review level
10.0 / 30
B · Technologies
15.9 / 35
C · Coverage
3.6 / 25
D · Class I / II technologies
0.0 / 10

The public score is calculated from public registration information and does not reflect quality of care. Scoring method →

Overall ranking

No. 1626of 1736

Registered technologies
3
Areas covered
1

Technology areas · Rank

Position in the overall score distribution

0–100 · Public score
000–9.9 · 0 institutions
01010–19.9 · 0 institutions
2172020–29.9 · 217 institutions
3163030–39.9 · 316 institutions
7564040–49.9 · 756 institutions
2465050–59.9 · 246 institutions
1326060–69.9 · 132 institutions
417070–79.9 · 41 institutions
248080–89.9 · 24 institutions
49090–100 · 4 institutions
This institution 29.5
Public score →100

Registered technologies (3)

NK and immune cells 3
Registered technologies · Japanese originalTechnology areasPlan classification
複合免疫療法(がんの治療、予防および免疫力改善を期待する複合型免疫細胞療法)NK and immune cellsClass III
αβT免疫細胞療法 (別名:CAT療法[CD3-activated T cell therapy]、活性化自己リンパ球療法[autologous activated lymphocyte therapy])NK and immune cellsClass III
活性化自己NK細胞療法NK and immune cellsClass III

Certified committee for regenerative medicine

  • 同仁会認定再生医療等委員会
  • 患者の集いモミの木再生医療等委員会

Public document number

  • 01C2407045
  • 02C2601081
  • 02C2601082
Plan classification · Certified committee for regenerative medicine · Public document number
Registered technologiesPlan classificationCertified committee for regenerative medicinePublic document number
複合免疫療法(がんの治療、予防および免疫力改善を期待する複合型免疫細胞療法)Class III同仁会認定再生医療等委員会01C2407045
αβT免疫細胞療法 (別名:CAT療法[CD3-activated T cell therapy]、活性化自己リンパ球療法[autologous activated lymphocyte therapy])Class III患者の集いモミの木再生医療等委員会02C2601081
活性化自己NK細胞療法Class III患者の集いモミの木再生医療等委員会02C2601082

Other institutions in the same prefecture

← Institution directory
One-to-one advice

Still unsure? Ask an advisor

Use the “Chat with an advisor” button on this page (at the bottom of the screen on mobile, bottom right on desktop) to open a chat with the Stem Cell Japan advice desk. Consultation and coordination are free, and an advisor replies within one working day.

Chat with an advisor